These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 8281671)

  • 1. Arterial diastolic pressure augmentation by intra-aortic balloon counterpulsation enhances the onset of coronary artery reperfusion by thrombolytic therapy.
    Gurbel PA; Anderson RD; MacCord CS; Scott H; Komjathy SF; Poulton J; Stafford JL; Godard J
    Circulation; 1994 Jan; 89(1):361-5. PubMed ID: 8281671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accelerated intravenous dosing of recombinant tissue-type plasminogen activator causes rapid but unstable reperfusion in a canine model of acute myocardial infarction.
    Gurbel PA; Anderson RD; MacCord CS; Scott H; Serebruany V; Herzog WR
    Coron Artery Dis; 1994 Nov; 5(11):929-36. PubMed ID: 7719525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraaortic balloon counterpulsation enhances coronary thrombolysis induced by intravenous administration of a thrombolytic agent.
    Prewitt RM; Gu S; Schick U; Ducas J
    J Am Coll Cardiol; 1994 Mar; 23(3):794-8. PubMed ID: 8113566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxygen radical scavenging agents as adjuvant therapy with tissue plasminogen activator in a canine model of coronary thrombolysis.
    Przyklenk K; Kloner RA
    Cardiovasc Res; 1993 Jun; 27(6):925-34. PubMed ID: 8221780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase in coronary blood flow by intra-aortic balloon counterpulsation in a porcine model of myocardial reperfusion.
    Bonios MJ; Pierrakos CN; Argiriou M; Dalianis A; Terrovitis JV; Dolou P; Drakos SG; Koudoumas D; Charitos CE; Anastasiou-Nana MI
    Int J Cardiol; 2010 Feb; 138(3):253-60. PubMed ID: 18805599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved regional myocardial blood flow, left ventricular unloading, and infarct salvage using an axial-flow, transvalvular left ventricular assist device. A comparison with intra-aortic balloon counterpulsation and reperfusion alone in a canine infarction model.
    Smalling RW; Cassidy DB; Barrett R; Lachterman B; Felli P; Amirian J
    Circulation; 1992 Mar; 85(3):1152-9. PubMed ID: 1537113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aortic counterpulsation may improve late patency of the occluded coronary artery in patients with early failure of thrombolytic therapy.
    Kono T; Morita H; Nishina T; Fujita M; Onaka H; Hirota Y; Kawamura K; Fujiwara A
    J Am Coll Cardiol; 1996 Oct; 28(4):876-81. PubMed ID: 8837563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombolysis and reocclusion in experimental jugular vein and coronary artery thrombosis. Effects of a plasminogen activator inhibitor type 1-neutralizing monoclonal antibody.
    Biemond BJ; Levi M; Coronel R; Janse MJ; ten Cate JW; Pannekoek H
    Circulation; 1995 Feb; 91(4):1175-81. PubMed ID: 7850956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathological basis of failure of concurrent glyceryl trinitrate therapy to improve efficacy of tissue type plasminogen activator in coronary thrombosis.
    Nicolini FA; Nichols WW; Saldeen TG; Mehta JL
    Cardiovasc Res; 1991 Apr; 25(4):283-9. PubMed ID: 1909212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced coronary flow velocity during intra-aortic balloon pumping assessed by transthoracic Doppler echocardiography.
    Takeuchi M; Nohtomi Y; Yoshitani H; Miyazaki C; Sakamoto K; Yoshikawa J
    J Am Coll Cardiol; 2004 Feb; 43(3):368-76. PubMed ID: 15013116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanical assistance by intra-aortic balloon pump counterpulsation during reperfusion increases coronary blood flow and mitigates the no-reflow phenomenon: an experimental study.
    Pierrakos CN; Bonios MJ; Drakos SG; Charitos EI; Tsolakis EJ; Ntalianis A; Nanas SN; Charitos CE; Nanas JN; Terrovitis JV
    Artif Organs; 2011 Sep; 35(9):867-74. PubMed ID: 21726241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of intra-aortic balloon counterpulsation on coronary blood flow velocity distal to coronary artery stenoses.
    Anderson RD; Gurbel PA
    Cardiology; 1996; 87(4):306-12. PubMed ID: 8793165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjunctive therapy with low molecular weight heparin with recombinant tissue-type plasminogen activator causes sustained reflow in canine coronary thrombosis.
    Nicolini FA; Nichols WW; Saldeen TG; Khan S; Mehta JL
    Am Heart J; 1992 Aug; 124(2):280-8. PubMed ID: 1322029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of intra-aortic balloon counterpulsation on left ventricular functional recovery early after acute myocardial infarction: a randomized experimental magnetic resonance imaging study.
    Azevedo CF; Amado LC; Kraitchman DL; Gerber BL; Edvardsen T; Osman NF; Rochitte CE; Wu KC; Lima JA
    Eur Heart J; 2005 Jun; 26(12):1235-41. PubMed ID: 15716282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intra-aortic balloon pumping and variations in flow in the dilated coronary artery in acute myocardial infarction].
    Prunier F; Furber A; Delépine S; Merheb M; Geslin P
    Arch Mal Coeur Vaiss; 2003 Apr; 96(4):317-23. PubMed ID: 12741308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of time of 7E3 administration on rt-PA-induced reperfusion: study in a canine model of thrombus-based occlusion-reperfusion.
    Rebello SS; Huang J; Saito K; Saucedo JF; Bates ER; Lucchesi BR
    Eur J Pharmacol; 1999 Jun; 374(3):399-410. PubMed ID: 10422784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conjunctive enhancement of enzymatic thrombolysis and prevention of thrombotic reocclusion with the selective factor Xa inhibitor, tick anticoagulant peptide. Comparison to hirudin and heparin in a canine model of acute coronary artery thrombosis.
    Sitko GR; Ramjit DR; Stabilito II; Lehman D; Lynch JJ; Vlasuk GP
    Circulation; 1992 Feb; 85(2):805-15. PubMed ID: 1735171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous administration of recombinant tissue plasminogen activator. Optimizing the rate of coronary thrombolysis.
    Prewitt RM; Gu S; Schick U; Ducas J
    Chest; 1995 Apr; 107(4):1146-51. PubMed ID: 7705128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced myocardial salvage by maintenance of microvascular patency following initial thrombolysis with recombinant tissue plasminogen activator.
    Longridge DJ; Follenfant MJ; Maxwell MP; Ford AJ; Hughes B
    Cardiovasc Res; 1990 Sep; 24(9):697-706. PubMed ID: 2121357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single bolus administration of recombinant tissue plasminogen activator: effects on infarct related vessel patency, microvascular perfusion, and microvascular reocclusion in a canine model of thrombotic occlusion/reperfusion.
    Longridge DJ; Follenfant MJ; Ford AJ
    Cardiovasc Res; 1991 Mar; 25(3):184-91. PubMed ID: 1903080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.